BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30829289)

  • 1. The effects of single versus combined therapy using LIM-kinase 2 inhibitor and type 5 phosphodiesterase inhibitor on erectile function in a rat model of cavernous nerve injury-induced erectile dysfunction.
    Cho MC; Lee J; Park J; Oh S; Chai JS; Son H; Paick JS; Kim SW
    Asian J Androl; 2019; 21(5):493-500. PubMed ID: 30829289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of inhibiting LIM-kinase2 in improving erectile function through suppression of corporal fibrosis in a rat model of cavernous nerve injury.
    Park J; Cho SY; Park K; Chai JS; Son H; Kim SW; Paick JS; Cho MC
    Asian J Androl; 2018; 20(4):372-378. PubMed ID: 29516877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of LIM-kinase 2 and Jun Amino-terminal Kinase Inhibitors Improves Erectile Function in a Rat Model of Cavernous Nerve Injury.
    Kim SW; Lee J; Park J; Chai JS; Oh S; Paick JS; Cho MC
    Urology; 2019 Sep; 131():136-143. PubMed ID: 31202856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of LIMK2 inhibitors alleviates cavernosal veno-occlusive dysfunction through suppression of cavernosal fibrosis in a rat model of erectile dysfunction after cavernosal nerve injury.
    Park J; Son H; Chai JS; Kim SW; Paick JS; Cho MC
    PLoS One; 2019; 14(3):e0213586. PubMed ID: 30870492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Rho-Kinase/LIM Kinase/Cofilin Signaling Pathway in Corporal Fibrosis after Cavernous Nerve Injury in Male Rats.
    Song SH; Park K; Kim SW; Paick JS; Cho MC
    J Sex Med; 2015 Jul; 12(7):1522-32. PubMed ID: 25923835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury.
    Lee CH; Kim HS; Goo MJ; Kang KK; Ahn BO; Kim SH; Yang DY
    J Sex Med; 2011 May; 8(5):1330-40. PubMed ID: 21366883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring erectile function by combined treatment with JNK inhibitor and HDAC inhibitor in a rat model of cavernous nerve injury.
    Lee J; Cho MC; Son H; Kim SW
    Andrology; 2022 May; 10(4):758-766. PubMed ID: 35023296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of erectile function by a combination of antiapoptosis by JNK inhibitor and preservation of smooth muscle or endothelium by hepatocyte growth factor in a rat model of cavernous nerve injury.
    Kim SW; Lee J; Oh S; Son H; Cho MC
    Prostate; 2022 Jan; 82(1):49-58. PubMed ID: 34609772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.
    Cho MC; Lee J; Park J; Kim SW
    World J Mens Health; 2021 Jul; 39(3):541-549. PubMed ID: 32777863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Jun N-terminal Kinase Improves Erectile Function by Alleviation of Cavernosal Apoptosis in a Rat Model of Cavernous Nerve Injury.
    Park J; Chai JS; Kim SW; Paick JS; Cho MC
    Urology; 2018 Mar; 113():253.e9-253.e16. PubMed ID: 29203189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of erectile function by suppression of corporal apoptosis, fibrosis and corporal veno-occlusive dysfunction with rho-kinase inhibitors in a rat model of cavernous nerve injury.
    Cho MC; Park K; Kim SW; Paick JS
    J Urol; 2015 May; 193(5):1716-23. PubMed ID: 25444982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy with a JNK Inhibitor and Hepatocyte Growth Factor for Restoration of Erectile Function in a Rat Model of Cavernosal Nerve Injury: Comparison with a JNK Inhibitor Alone or Hepatocyte Growth Factor Alone.
    Lee J; Kim SW; Cho MC
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of erectile function and responsiveness to phosphodiesterase type 5 inhibitors at different stages of streptozotocin-induced diabetes in rats.
    Cho SY; Park K; Paick JS; Kim SW
    J Sex Med; 2011 May; 8(5):1352-61. PubMed ID: 21054802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate.
    Mulhall JP; Müller A; Donohue JF; Mullerad M; Kobylarz K; Paduch DA; Tal R; Li PS; Cohen-Gould L; Scardino PT
    J Sex Med; 2008 May; 5(5):1126-1136. PubMed ID: 18331274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury.
    Song KM; Chung JS; Choi MJ; Jin HR; Yin GN; Kwon MH; Park JM; Kim WJ; Lee SJ; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2014 Jan; 11(1):51-63. PubMed ID: 24433558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectification of cavernosal fibrosis and veno-occlusive dysfunction by administration of suberoylanilide hydroxamic acid in a rat model of cavernosal nerve injury: Comparison with a PDE5 inhibitor.
    Cho MC; Lee J; Son H; Kim SW
    Andrology; 2021 Mar; 9(2):720-727. PubMed ID: 33064925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2-10aa-PGIS gene therapy improves erectile function in rats after cavernous nerve injury.
    Lin H; Yuan J; Ruan KH; Yang W; Zhang J; Dai Y; Wang R
    J Sex Med; 2013 Jun; 10(6):1476-87. PubMed ID: 23551902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes.
    Zhou F; Xin H; Liu T; Li GY; Gao ZZ; Liu J; Li WR; Cui WS; Bai GY; Park NC; Xin ZC
    J Androl; 2012; 33(5):832-44. PubMed ID: 22403279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of Human Urine-Derived Stem Cells Transfected with Pigment Epithelium-Derived Factor to Protect Erectile Function in a Rat Model of Cavernous Nerve Injury.
    Yang Q; Chen X; Zheng T; Han D; Zhang H; Shi Y; Bian J; Sun X; Xia K; Liang X; Liu G; Zhang Y; Deng C
    Cell Transplant; 2016 Nov; 25(11):1987-2001. PubMed ID: 27075964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)/brain-derived neurotrophic factor (BDNF)-membrane system in a rat model of cavernous nerve injury.
    Jeong HH; Piao S; Ha JN; Kim IG; Oh SH; Lee JH; Cho HJ; Hong SH; Kim SW; Lee JY
    Urology; 2013 May; 81(5):1108.e7-14. PubMed ID: 23522997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.